DRD2 and familial pancreatic carcinoma: In pancreatic cancer, DRD2 inhibition by pimozide resulted in anticancer activity by inducing cell death through activating the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway leading to higher calcium levels and elevated ER stress, thus inducing apoptosis [17].